Trial Profile
Non-inferiority Trial of Oral Tranexamic Acid (OTA) vs. Intravenous Tranexamic Acid (IVTA) to Prevent Blood Loss in Joint Replacement Surgery
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2018
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Postoperative complications
- Focus Therapeutic Use
- 12 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 May 2015 New trial record